MPCI Stock Overview
A drug holding company, produces and sells pharmaceutical products for human and veterinary use in Egypt and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 5/6 |
| Financial Health | 6/6 |
| Dividends | 3/6 |
Memphis Pharmaceuticals & Chemical Industries Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ج.م88.91 |
| 52 Week High | ج.م139.99 |
| 52 Week Low | ج.م30.52 |
| Beta | 0.27 |
| 11 Month Change | 16.73% |
| 3 Month Change | -1.93% |
| 1 Year Change | 176.20% |
| 33 Year Change | 198.26% |
| 5 Year Change | 926.67% |
| Change since IPO | 194.19% |
Recent News & Updates
Recent updates
Shareholder Returns
| MPCI | EG Pharmaceuticals | EG Market | |
|---|---|---|---|
| 7D | 6.2% | 0.2% | 2.4% |
| 1Y | 176.2% | 27.3% | 62.0% |
Return vs Industry: MPCI exceeded the EG Pharmaceuticals industry which returned 27.3% over the past year.
Return vs Market: MPCI exceeded the EG Market which returned 62% over the past year.
Price Volatility
| MPCI volatility | |
|---|---|
| MPCI Average Weekly Movement | 7.6% |
| Pharmaceuticals Industry Average Movement | 4.0% |
| Market Average Movement | 6.3% |
| 10% most volatile stocks in EG Market | 9.0% |
| 10% least volatile stocks in EG Market | 3.3% |
Stable Share Price: MPCI has not had significant price volatility in the past 3 months.
Volatility Over Time: MPCI's weekly volatility (8%) has been stable over the past year, but is still higher than 75% of EG stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1940 | n/a | Bassem Abdullah | www.memphis.com.eg |
Memphis Pharmaceuticals & Chemical Industries, a drug holding company, produces and sells pharmaceutical products for human and veterinary use in Egypt and internationally. The company offers human health products in various therapeutic areas, including anti-infective, CNS, dermatological, cardio vascular system, corticosteroid, vitamins and minerals, musculo-skeletal system, analgesic and antipyretic, respiratory system, genitourinary system, alimentary tract and metabolism, antihistaminic, antiparasites, and hormones. It also provides animal health products in powder form, as well as in oral and injectable solution forms.
Memphis Pharmaceuticals & Chemical Industries Fundamentals Summary
| MPCI fundamental statistics | |
|---|---|
| Market cap | ج.م500.12m |
| Earnings (TTM) | ج.م221.75m |
| Revenue (TTM) | ج.م887.94m |
2.3x
P/E Ratio0.6x
P/S RatioIs MPCI overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| MPCI income statement (TTM) | |
|---|---|
| Revenue | ج.م887.94m |
| Cost of Revenue | ج.م583.32m |
| Gross Profit | ج.م304.62m |
| Other Expenses | ج.م82.88m |
| Earnings | ج.م221.75m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 39.42 |
| Gross Margin | 34.31% |
| Net Profit Margin | 24.97% |
| Debt/Equity Ratio | 317.3% |
How did MPCI perform over the long term?
See historical performance and comparison